Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guerin (BCG) as a prevention against TB. BCG protects against disseminated disease...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Hopkins, R, Bridgeman, A, Joseph, J, Gilbert, S, McShane, H, Hanke, T
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Public Library of Science 2011

समान संसाधन

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
द्वारा: Richard Hopkins, और अन्य
प्रकाशित: (2011-01-01)

Vaccine strategies against tuberculosis
द्वारा: H McShane
प्रकाशित: (2009-03-01)

Vaccines for tuberculosis
द्वारा: McShane, H
प्रकाशित: (2013)

Vaccine Platform for Prevention of Mother-to-Child Transmission of HIV-1 through Breastfeeding
द्वारा: Im, E, और अन्य
प्रकाशित: (2008)

Insights and challenges in tuberculosis vaccine development
द्वारा: McShane, H
प्रकाशित: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
द्वारा: McShane, H
प्रकाशित: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
द्वारा: McShane, H
प्रकाशित: (2011)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
द्वारा: Christopher J. De Voss, और अन्य
प्रकाशित: (2025-02-01)

Vaccination against tuberculosis: how can we better BCG?
द्वारा: Pitt, J, और अन्य
प्रकाशित: (2013)

Vaccination against tuberculosis: How can we better BCG?
द्वारा: Pitt, J, और अन्य
प्रकाशित: (2013)

Tuberculosis vaccines: Progress and challenges
द्वारा: Checkley, A, और अन्य
प्रकाशित: (2011)

Vaccine strategies against tuberculosis.
द्वारा: Mcshane, H
प्रकाशित: (2009)

Developing an improved vaccine against tuberculosis.
द्वारा: Mcshane, H
प्रकाशित: (2004)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
द्वारा: McShane, H
प्रकाशित: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
द्वारा: Davenne, T, और अन्य
प्रकाशित: (2016)

Clinical testing of tuberculosis vaccine candidates
द्वारा: Hatherill, M, और अन्य
प्रकाशित: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
द्वारा: Vermaak, S, और अन्य
प्रकाशित: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
द्वारा: Tanner, R, और अन्य
प्रकाशित: (2016)

WHO preferred product characteristics for new vaccines against tuberculosis
द्वारा: Schrager, L, और अन्य
प्रकाशित: (2018)

Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
द्वारा: Im, E, और अन्य
प्रकाशित: (2007)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
द्वारा: Dockrell, HM, और अन्य
प्रकाशित: (2022)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
द्वारा: Griffiths, K, और अन्य
प्रकाशित: (2013)

Construction and characterization of recombinant MTBVAC. HIV, a new live attenuated vaccine against HIV and tuberculosis
द्वारा: Saubi, N, और अन्य
प्रकाशित: (2018)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
द्वारा: Hazel M. Dockrell, और अन्य
प्रकाशित: (2022-05-01)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
द्वारा: Villarreal-Ramos, B, और अन्य
प्रकाशित: (2017)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
द्वारा: Sander, C, और अन्य
प्रकाशित: (2007)

Human and Bovine Tuberculosis
द्वारा: McShane, H
प्रकाशित: (2016)

MTBVAC-based TB-HIV vaccine is safe, elicits HIV-T cell responses, and protects against Mycobacterium tuberculosis in Mice
द्वारा: Broset, E, और अन्य
प्रकाशित: (2019)

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine.
द्वारा: Bridgeman, A, और अन्य
प्रकाशित: (2009)

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
द्वारा: Esther Broset, और अन्य
प्रकाशित: (2019-06-01)

Identification of antigens presented by MHC for vaccines against tuberculosis
द्वारा: Bettencourt, P, और अन्य
प्रकाशित: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
द्वारा: Bettencourt, P, और अन्य
प्रकाशित: (2020)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
द्वारा: Stylianou, E, और अन्य
प्रकाशित: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
द्वारा: Dean, G, और अन्य
प्रकाशित: (2014)

MVA as a vector for vaccines against HIV-1.
द्वारा: Im, E, और अन्य
प्रकाशित: (2004)

Engineering a dual vaccine against COVID-19 and tuberculosis
द्वारा: Carlyn Monèt Guthrie, और अन्य
प्रकाशित: (2023-10-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
द्वारा: McShane, H
प्रकाशित: (2020)

Local pulmonary immunological biomarkers in tuberculosis
द्वारा: Morrison, H, और अन्य
प्रकाशित: (2021)

Local Pulmonary Immunological Biomarkers in Tuberculosis
द्वारा: Hazel Morrison, और अन्य
प्रकाशित: (2021-03-01)

Tuberculosis vaccines in clinical trials.
द्वारा: Rowland, R, और अन्य
प्रकाशित: (2011)